The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Skyline Diagnostics
Leadership - Skyline Diagnostics
Stock and Other Ownership Interests - Skyline Diagnostics
Honoraria - SciBase
Prognostic significance of the CP-GEP assay combining clinicopathologic factors and gene expression profiling in patients (pts) with AJCC v8 stage I/II cutaneous melanoma (CM).
 
Teresa Maria Santos Amaral
Honoraria - CeCaVa; Novartis
Consulting or Advisory Role - CeCaVa
Research Funding - NeraCare GmbH (Inst); Novartis (Inst); Sanofi (Inst); Skyline Diagnostics (Inst)
 
Tobias Sinnberg
Research Funding - Novartis (Inst)
 
Eftychia Chatziioannou
No Relationships to Disclose
 
Heike Niessner
Research Funding - Novartis (Inst)
 
Ulrike M. Leiter
Consulting or Advisory Role - MSD; Novartis; Roche; Sanofi; Sun Pharma
Research Funding - MSD (Inst)
 
Ulrike Keim
No Relationships to Disclose
 
Andrea Forschner
Honoraria - Bristol-Myers Squibb; CeGaT; MSD Oncology; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche Pharma AG
Research Funding - Stiftung Immunonkologie/Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
 
Jvalini Dwarkasing
No Relationships to Disclose
 
Lisette Meerstein-Kessel
Employment - Skyline Diagnostics
Stock and Other Ownership Interests - Skyline Diagnostics
 
Thomas Rademaker
Employment - Skyline Diagnostics
 
Renske Wever
Employment - Skyline Diagnostics
Stock and Other Ownership Interests - Skyline Diagnostics
Research Funding - Skyline Diagnostics
 
Alexander M. Eggermont
Stock and Other Ownership Interests - IO Biotech; RiverD; Skyline Diagnostics
Honoraria - Agenus; BIOCAD; BIOINVENT; BioNTech; CatalYm; Ellipses Pharma; GlaxoSmithKline; IO Biotech; ISA Pharmaceuticals; Merck; MSD; NEKTAR; Novartis; Pfizer; Sairopa; Sellas Life Sciences; Skyline Diagnostics
Consulting or Advisory Role - Agenus; BioCad; BIOINVENT; CatalYm; Ellipses Pharma; GlaxoSmithKline; IO Biotech; IO BIOTECH; ISA Pharmaceuticals; Merck; MSD; NEKTAR; Novartis; Pfizer; Sairopa; Sellas Life Sciences; Skyline Diagnostics
Speakers' Bureau - BIOCAD; Bristol-Myers Squibb.; Merck; MSD
 
Lukas Flatz
Stock and Other Ownership Interests - Hookipa Pharma
Honoraria - Bristol-Myers Squibb; Novartis; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Sanofi
Research Funding - Hookipa Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Hookipa Pharma
 
Stephan Forchhammer
Honoraria - Kyowa Kirin; Takeda
Research Funding - BioNTech (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)